Trial Details

COMPLETED
Basic Information
Clinical ID c639
Identifier NCT01346826
Trial Title Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease|Ulcerative Colitis
Interventions DRUG: Standard 2 hours-infusion|DRUG: Accelerated 1 hour-infusion|DRUG: Accelerated 30 minutes-infusion
Participant Information
Sponsor Asan Medical Center
City Seoul
Country/Region Korea, Republic of
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2025-05-11
Primary Completion Date 2025-10-15
Completion Date 2025-04-16